MedTrace Logo

PREMIUM, Observational Study

NCT01756625 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2012-12-27

No results posted yet for this study

Summary

PREMIUM is an observational pharmaco-epidemiologic, transversal, multi-centric, prospective cohort study and with independent investigators. The purpose is to compare PFS in real life with PFS clinical trials and to determine factors impacting efficacy and compliance to cetuximab treatment in first line K-ras wild-type (wt) metastatic colorectal cancer.

Conditions

  • First Line WT KRAS mCRC

Sponsors & Collaborators

  • Merck Serono International SA

    collaborator INDUSTRY

  • BESPIM, CHU Nîmes (data analysis)

    collaborator UNKNOWN

  • Dr.Laurent Mineur

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-03-31
Completion
2013-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01756625 on ClinicalTrials.gov